Dallas, TX -- (SBWire) -- 02/05/2015 --The report "Iron Deficiency Anemia – Pipeline Review, H1 2015 provides comprehensive information on the therapeutic development for Iron Deficiency Anemia. Iron deficiency anemia is a common type of anemia and occurs when body does not have sufficient mineral iron. Insufficient dietary iron, impaired iron absorption, bleeding or loss of body iron in the urine may be the cause. Iron deficiency anemia signs and symptoms include fatigue, leg cramps on climbing stairs, craving ice, poor scholastic performance, dysphagia with solid foods, reduced resistance to infection, cold intolerance, altered behavior and comorbid cardiac or pulmonary disease.
The report also reviews key players involved in the therapeutic development for Iron Deficiency Anemia and special features on late-stage and discontinued projects. Companies discussed in this Iron Deficiency Anemia – Pipeline Review, H1 2015 report include Panion & Bf Biotech Inc, Rockwell Medical, Inc., Vifor Pharma AG.
Treatment on iron deficiency anemia may include taking iron supplements and eating iron-rich foods. Iron-rich foods include: chicken and turkey, dried lentils, peas, beans, fish, meats, peanut butter, soybeans and whole-grain bread. Drugs profiles discuss in this report include ferric carboxymaltose, ferric citrate, ferric pyrophosphate citrate, NSC-8679, Proteins to Activate Erythroferrone for Iron Deficiency Anemia, ST-10, and VIT-91. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=269558 . (This is a premium report priced at US$2000 for a single user License.)
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Featured News & Press Releases
- Dec 15, 2014: American Regent's Injectafer (ferric carboxymaltose injection) Assigned J Code by Centers for Medicare & Medicaid Services
- Dec 08, 2014: American Regent Announces Clinical Data Presentations at ASH 2014
- Nov 11, 2014: Three clinical Presentations Highlight Novel Iron Replacement Drug Triferic at ASN
- Oct 09, 2014: Rockwell Medical Announces FDA Advisory Committee Review of Triferic For The Treatment Of Iron Replacement And Maintenance Of Hemoglobin In Hemodialysis Patients
- Sep 01, 2014: CONFIRM-HF study demonstrates that Ferinject improves exercise capacity in patients with chronic heart failure
- Jul 15, 2014: American Regent's Injectafer (Ferric Carboxymaltose Injection) Now the Fastest Growing IV Iron in United States
- Jun 09, 2014: Rockwell Medical Wins Appeal for Determination as Small Business for New Drug Application Filing for Triferic
- Jun 02, 2014: Faster, more affordable treatment for Iron Deficiency Anaemia now available in Australia
- May 28, 2014: Rockwell Medical Announces FDA Acceptance for Filing of Triferic New Drug Application
- May 22, 2014: Keryx Receives Notification of PDUFA Date Extension for Zerenex
Inquire before Buying @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=269558. (This is a premium report priced at US$2000 for a single user License.)
List of Tables
Number of Products under Development for Iron Deficiency Anemia, H1 2015
Number of Products under Development for Iron Deficiency Anemia - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Investigation by Universities/Institutes, H1 2015
Iron Deficiency Anemia - Pipeline by Panion & Bf Biotech Inc, H1 2015
Iron Deficiency Anemia - Pipeline by Rockwell Medical, Inc., H1 2015
Iron Deficiency Anemia - Pipeline by Vifor Pharma AG, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Iron Deficiency Anemia Therapeutics - Recent Pipeline Updates, H1 2015
Iron Deficiency Anemia - Dormant Projects, H1 2015
Explore more reports on Anemia Drugs Market at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/diseases-treatment/anemia-drugs.
Iron Deficiency Anemia Therapeutics Pipeline Market H1 2015 Research Report Available at RnRMarketResearch.com
RnRMarketResearch.com adds “Iron Deficiency Anemia – Pipeline Review, H1 2015” report to its store. The report provides an overview of the Iron Deficiency Anemia’s therapeutic pipeline.